Page 83 - Read Online
P. 83

Page 10 of 11                   Raval et al. Vessel Plus 2024;8:5  https://dx.doi.org/10.20517/2574-1209.2023.99

                   2021;143:e72-227.  DOI
               6.       Tang GHL, Verma S, Bhatt DL. Transcatheter aortic valve replacement in low-risk patients: a new era in the treatment of aortic
                   stenosis. Circulation 2019;140:801-3.  DOI  PubMed
               7.       Lim GB. Suitability of TAVI in low-risk patients. Nat Rev Cardiol 2023;20:284.  DOI  PubMed
               8.       Cangemi S, Aurigemma C, Romagnoli E, et al. Management of concomitant coronary artery disease and aortic valve stenosis in the era
                   of transcatheter aortic valve treatment. Mini-Invasive Surg 2022;6:3.  DOI
               9.       Sankaramangalam K, Banerjee K, Kandregula K, et al. Impact of coronary artery disease on 30-day and 1-year mortality in patients
                   undergoing transcatheter aortic valve replacement: a meta-analysis. J Am Heart Assoc 2017;6:e006092.  DOI  PubMed  PMC
               10.      Safarian H, Alidoosti M, Shafiee A, Salarifar M, Poorhosseini H, Nematipour E. The SYNTAX score can predict major adverse
                   cardiac events following percutaneous coronary intervention. Heart Views 2014;15:99-105.  DOI  PubMed  PMC
               11.      Puymirat E, Didier R, Eltchaninoff H, et al. Impact of coronary artery disease in patients undergoing transcatheter aortic valve
                   replacement: insights from the FRANCE-2 registry. Clin Cardiol 2017;40:1316-22.  DOI  PubMed  PMC
               12.      D'Ascenzo F, Verardi R, Visconti M, et al. Independent impact of extent of coronary artery disease and percutaneous revascularisation
                   on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results. EuroIntervention 2018;14:e1169-77.
                   DOI
               13.      Witberg G, Zusman O, Codner P, Assali A, Kornowski R. Impact of coronary artery revascularization completeness on outcomes of
                   patients with coronary artery disease undergoing transcatheter aortic valve replacement: a meta-analysis of studies using the residual
                   SYNTAX score (synergy between PCI with taxus and cardiac surgery). Circ Cardiovasc Interv 2018;11:e006000.  DOI  PubMed
               14.      Stefanini GG, Stortecky S, Cao D, et al. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX
                   score in patients undergoing transcatheter aortic valve implantation. Eur Heart J 2014;35:2530-40.  DOI
               15.      Khawaja MZ, Asrress KN, Haran H, et al. The effect of coronary artery disease defined by quantitative coronary angiography and
                   SYNTAX score upon outcome after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. EuroIntervention
                   2015;11:450-5.  DOI
               16.      de Azevedo Filho AFB, Accorsi TA, Ribeiro HB. Coronary artery disease in patients with aortic stenosis and transcatheter aortic
                   valve implantation: implications for management. Eur Cardiol 2021;16:e49.  DOI  PubMed  PMC
               17.      Chieffo A, Giustino G, Spagnolo P, et al. Routine screening of coronary artery disease with computed tomographic coronary
                   angiography in place of invasive coronary angiography in patients undergoing transcatheter aortic valve replacement. Circ Cardiovasc
                   Interv 2015;8:e002025.  DOI
               18.      van den Boogert TPW, Vendrik J, Claessen BEPM, et al. CTCA for detection of significant coronary artery disease in routine TAVI
                   work-up: a systematic review and meta-analysis. Neth Heart J 2018;26:591-9.  DOI  PubMed  PMC
               19.      van den Boogert TPW, Claessen BEPM, Opolski MP, et al. DEtection of ProxImal coronary stenosis in the work-up for Transcatheter
                   aortic valve implantation using CTA (from the DEPICT CTA collaboration). Eur Radiol 2022;32:143-51.  DOI  PubMed  PMC
               20.      Mathew RC, Gottbrecht M, Salerno M. Computed tomography fractional flow reserve to guide coronary angiography and intervention.
                   Interv Cardiol Clin 2018;7:345-54.  DOI  PubMed  PMC
               21.      Michail M, Ihdayhid AR, Comella A, et al. Feasibility and validity of computed tomography-derived fractional flow reserve in patients
                   with severe aortic stenosis: the CAST-FFR study. Circ Cardiovasc Interv 2021;14:e009586.  DOI  PubMed  PMC
               22.      Peper J, Schaap J, Kelder JC, et al. Added value of computed tomography fractional flow reserve in the diagnosis of coronary artery
                   disease. Sci Rep 2021;11:6748.  DOI  PubMed  PMC
               23.      Kalisz K, Buethe J, Saboo SS, Abbara S, Halliburton S, Rajiah P. Artifacts at cardiac CT: physics and solutions. Radiographics
                   2016;36:2064-83.  DOI  PubMed
               24.      Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease: developed by the
                   task force for the management of valvular heart disease of the European society of cardiology (ESC) and the European association for
                   cardio-thoracic surgery (EACTS). Eur Heart J 2021;43:561-632.  DOI
               25.      Stanojevic D, Gunasekaran P, Tadros P, et al. Intravenous adenosine infusion is safe and well tolerated during coronary fractional flow
                   reserve assessment in elderly patients with severe aortic stenosis. J Invasive Cardiol 2016;28:357-61.  PubMed
               26.      Katta N, Abbott JD, Kalra A, et al. Management of coronary artery disease in the setting of transcatheter aortic valve replacement.
                   Heart Int 2020;14:24-8.  DOI  PubMed  PMC
               27.      Ahmad Y, Götberg M, Cook C, et al. Coronary hemodynamics in patients with severe aortic stenosis and coronary artery disease
                   undergoing transcatheter aortic valve replacement: implications for clinical indices of coronary stenosis severity. JACC Cardiovasc
                   Interv 2018;11:2019-31.  DOI  PubMed  PMC
               28.      Pesarini G, Scarsini R, Zivelonghi C, et al. Functional assessment of coronary artery disease in patients undergoing transcatheter aortic
                   valve implantation: influence of pressure overload on the evaluation of lesions severity. Circ Cardiovasc Interv 2016;9:e004088.  DOI
               29.      Götberg M, Cook CM, Sen S, Nijjer S, Escaned J, Davies JE. The evolving future of instantaneous wave-free ratio and fractional flow
                   reserve. J Am Coll Cardiol 2017;70:1379-402.  DOI  PubMed
               30.      Scarsini R, Pesarini G, Lunardi M, et al. Observations from a real-time, iFR-FFR “hybrid approach” in patients with severe aortic
                   stenosis and coronary artery disease undergoing TAVI. Cardiovasc Revasc Med 2018;19:355-9.  DOI
               31.      Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease:
                   executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am
                   Coll Cardiol 2014;63:2438-88.  DOI
   78   79   80   81   82   83   84   85   86   87   88